202 related articles for article (PubMed ID: 36139375)
21. Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids.
Buenafe AC; Dorrell C; Reddy AP; Klimek J; Marks DL
Sci Rep; 2022 Mar; 12(1):3556. PubMed ID: 35241737
[TBL] [Abstract][Full Text] [Related]
22. Utility of serum CA19-9 levels in the diagnosis of pancreatic ductal adenocarcinoma in an endoscopic ultrasound referral population.
Parikh DA; Durbin-Johnson B; Urayama S
J Gastrointest Cancer; 2014 Mar; 45(1):74-9. PubMed ID: 24272911
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-20a in extracellular vesicles derived from duodenal fluid is a possible biomarker for pancreatic ductal adenocarcinoma.
Taniguchi T; Ideno N; Araki T; Miura S; Yamamoto M; Nakafusa T; Higashijima N; Yamamoto T; Tamura K; Nakamura S; Abe T; Ikenaga N; Nakata K; Ohuchida K; Oda Y; Ohtsuka T; Nakamura M
DEN Open; 2024 Apr; 4(1):e333. PubMed ID: 38434144
[TBL] [Abstract][Full Text] [Related]
24. Mutant
Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
[TBL] [Abstract][Full Text] [Related]
25. Liquid biopsies in pancreatic cancer.
Kamyabi N; Bernard V; Maitra A
Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
[No Abstract] [Full Text] [Related]
26. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
Li H; Chiang CL; Kwak KJ; Wang X; Doddi S; Ramanathan LV; Cho SM; Hou YC; Cheng TS; Mo X; Chang YS; Chang HL; Cheng W; Tsai WN; Nguyen LTH; Pan J; Ma Y; Rima XY; Zhang J; Reategui E; Chu YS; Chang PM; Chang PH; Huang CF; Wang CH; Shan YS; Li CP; Fleisher M; Lee LJ
Adv Sci (Weinh); 2024 Mar; 11(11):e2306373. PubMed ID: 38204202
[TBL] [Abstract][Full Text] [Related]
27. Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.
Cui M; Shoucair S; Liao Q; Qiu X; Kinny-Köster B; Habib JR; Ghabi EM; Wang J; Shin EJ; Leng SX; Ali SZ; Thompson ED; Zimmerman JW; Shubert CR; Lafaro KJ; Burkhart RA; Burns WR; Zheng L; He J; Zhao Y; Wolfgang CL; Yu J
Int J Surg; 2023 Feb; 109(2):99-106. PubMed ID: 36799816
[TBL] [Abstract][Full Text] [Related]
28. Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment.
Zhang W; Campbell DH; Walsh BJ; Packer NH; Liu D; Wang Y
J Nanobiotechnology; 2022 Oct; 20(1):446. PubMed ID: 36242076
[TBL] [Abstract][Full Text] [Related]
29. Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic adenocarcinoma.
Vikramdeo KS; Anand S; Khan MA; Khushman M; Heslin MJ; Singh S; Singh AP; Dasgupta S
Sci Rep; 2022 Nov; 12(1):18455. PubMed ID: 36323735
[TBL] [Abstract][Full Text] [Related]
30. CD9 mediates the uptake of extracellular vesicles from cancer-associated fibroblasts that promote pancreatic cancer cell aggressiveness.
Nigri J; Leca J; Tubiana SS; Finetti P; Guillaumond F; Martinez S; Lac S; Iovanna JL; Audebert S; Camoin L; Vasseur S; Bertucci F; Tomasini R
Sci Signal; 2022 Aug; 15(745):eabg8191. PubMed ID: 35917363
[TBL] [Abstract][Full Text] [Related]
31. miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer.
Ko J; Bhagwat N; Black T; Yee SS; Na YJ; Fisher S; Kim J; Carpenter EL; Stanger BZ; Issadore D
Cancer Res; 2018 Jul; 78(13):3688-3697. PubMed ID: 29735554
[TBL] [Abstract][Full Text] [Related]
32. Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma.
Kryza T; Khan T; Puttick S; Li C; Sokolowski KA; Tse BW; Cuda T; Lyons N; Gough M; Yin J; Parkin A; Deryugina EI; Quigley JP; Law RHP; Whisstock JC; Riddell AD; Barbour AP; Wyld DK; Thomas PA; Rose S; Snell CE; Pajic M; He Y; Hooper JD
Theranostics; 2020; 10(9):4116-4133. PubMed ID: 32226543
[No Abstract] [Full Text] [Related]
33. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.
Wang X; Li Y; Tian H; Qi J; Li M; Fu C; Wu F; Wang Y; Cheng D; Zhao W; Zhang C; Wang T; Rao J; Zhang W
BMC Cancer; 2014 Aug; 14():578. PubMed ID: 25106741
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
36. Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma.
Yu J; Ploner A; Kordes M; Löhr M; Nilsson M; de Maturana MEL; Estudillo L; Renz H; Carrato A; Molero X; Real FX; Malats N; Ye W
Int J Cancer; 2021 Apr; 148(8):2048-2058. PubMed ID: 33411965
[TBL] [Abstract][Full Text] [Related]
37. A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.
Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Fortis SP; Tzounakas VL; Anastasiadi AT; Sarantis P; Vasileiadi S; Tsagarakis A; Aloizos G; Manolakopoulos S; Deutsch M
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542378
[TBL] [Abstract][Full Text] [Related]
38. From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.
Montemagno C; Cassim S; Pouyssegur J; Broisat A; Pagès G
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517181
[TBL] [Abstract][Full Text] [Related]
39. Rapid Lipid-Based Approach for Normalization of Quantum-Dot-Detected Biomarker Expression on Extracellular Vesicles in Complex Biological Samples.
Rodrigues M; Richards N; Ning B; Lyon CJ; Hu TY
Nano Lett; 2019 Nov; 19(11):7623-7631. PubMed ID: 31317745
[TBL] [Abstract][Full Text] [Related]
40. New therapy for pancreatic cancer based on extracellular vesicles.
Araujo-Abad S; Manresa-Manresa A; Rodríguez-Cañas E; Fuentes-Baile M; García-Morales P; Mallavia R; Saceda M; de Juan Romero C
Biomed Pharmacother; 2023 Jun; 162():114657. PubMed ID: 37023623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
